Elicityl Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.01M
Latest Deal Amount
  • Investors
  • 4

Elicityl General Information

Description

Operator of a biotechnology agency intended to focus on complex life science engineering and production. The company's agency specializes in the supply of oligosaccharides and polysaccharides for biological applications targeting plant health, pharmacy, nutraceuticals and cosmetics, enabling clients to innovative industrial methods of production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Drug Discovery
Primary Office
  • 746 avenue Ambroise Croizat
  • 38920 Crolles
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elicityl Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 27-Sep-2015 $1.01M 00.000 Completed Profitable
2. Later Stage VC 25-Sep-2007 00000 00.000 Completed Generating Revenue
1. Early Stage VC $405K $405K Completed Startup
To view Elicityl’s complete valuation and funding history, request access »

Elicityl Executive Team (5)

Name Title Board Seat Contact Info
Henri Sors Chief Executive Officer, Managing Director & Chairman
Yvette Lienart Managing Director & Chairman
Joel Monnier Publishing Director and Propriétaire & Founder
Benoît Darblade Ph.D Director innovation and partnerships
You’re viewing 4 of 5 executive team members. Get the full list »

Elicityl Board Members (2)

Name Representing Role Since
Henri Sors Elicityl Chief Executive Officer, Managing Director & Chairman 000 0000
Yvette Lienart Elicityl Managing Director & Chairman 000 0000
To view Elicityl’s complete board members history, request access »

Elicityl Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elicityl Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Expansinvest PE/Buyout Minority 000 0000 000000 0
Rhône-Alpes Création Venture Capital Minority 000 0000 000000 0
Succès Europe Venture Capital Minority 000 0000 000000 0
To view Elicityl’s complete investors history, request access »